Intercos SpA

The Intercos share plunged 8.1% to €12.68 after private equity investor L Catterton, via its vehicle CP7, placed about 6 million shares (≈6.2% of capital) in an accelerated bookbuilding for roughly €81 million. The transaction, coordinated by UBS, Jefferies and BNP Paribas, increased the free float and put heavy pressure on the share. CP7’s stake fell from 13.33% to just above 7%, while founder Dario Gianandrea Ferrari remains anchor shareholder with about 48.64%. Macroeconomic factors such as higher inflation in the eurozone and interest rate expectations weighed on the market’s absorption capacity. » More on de.investing.com

Intercos posted net sales of EUR 285m in Q2 2026 (+5% at constant exchange rates) and a record EBITDA of EUR 47.5m, with a margin of 16.7%. The first half remains slightly down (net sales H1: EUR 512m), but management confirms the full-year guidance and considers the consensus EBITDA of around EUR 164m achievable. Order backlog rose in the mid‑teens percentage range, July was a record month, while Asia and skincare margins remain a challenge. The stock fell 1.5% after the announcement and was trading at $13.14. » More on de.investing.com

Intercos reports a Q3 2025 revenue decline of 5.3% to €260.7m, while adjusted EBITDA increased by 5.4% to €41.4m and the margin rose to 15.9%. For the first nine months, revenue rose to €785.6m (+1.4%) and adjusted EBITDA to €115.9m (+12.3%). The company sticks to its full-year guidance of around €155m adjusted EBITDA, has launched a share buyback program, expanded capacity in Asia and is shifting focus to higher‑margin make-up products (63% of sales). With net debt of €133.7m (net/net EBITDA 0.86x) Intercos sees itself well positioned, but in a challenging market it prioritizes profitability over revenue growth. » More on de.investing.com